Skip to main content
SINOTHERAPEUTICS INC. logo

SINOTHERAPEUTICS INC. — Investor Relations & Filings

Ticker · 688247 ISIN · CNE100005PL9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2026-04-29 Annual Report
Country CN China
Listing Shanghai Stock Exchange 688247

About SINOTHERAPEUTICS INC.

https://www.sinotph.com/en/

Sinotherapeutics Inc. is a pharmaceutical company specializing in the research, development, and commercialization of complex generic drugs and innovative drug delivery systems. The company focuses on high-barrier formulations, particularly oral solid dosage forms with modified-release or controlled-release profiles. Utilizing advanced technology platforms, Sinotherapeutics develops products designed to improve patient compliance and therapeutic outcomes. Its operations encompass the full lifecycle of drug development, from formulation design and clinical evaluation to large-scale manufacturing under global quality standards. The company maintains a robust pipeline targeting various therapeutic areas, including cardiovascular diseases, central nervous system disorders, and metabolic conditions. Sinotherapeutics aims to provide high-quality, affordable medications by leveraging its expertise in complex chemistry and pharmaceutical engineering.

Recent filings

Filing Released Lang Actions
2026年度“提质增效重回报”行动方案
Annual Report Classification · 95% confidence The document is a detailed company report discussing the 2025 performance and the 2026 action plan of Shanghai Xuantai Pharmaceutical Technology Co., Ltd. It includes comprehensive financial data such as revenue, net profit, R&D investment, product approvals, clinical trials, governance improvements, investor relations, dividend policy, and management incentives. The content covers a full year of company activity and financial performance, strategic plans, governance, and shareholder returns. It is not a brief announcement or a simple notice but a substantive report with financial and operational details for a fiscal year. Therefore, it fits the definition of an Annual Report (10-K). The document length (4881 characters) is sufficient to contain detailed financial and operational information, not just an announcement or summary. Hence, the classification is 10-K with high confidence.
2026-04-29 Chinese
上会会计师事务所（特殊普通合伙）关于上海宣泰医药科技股份有限公司2025年度募集资金存放、管理与实际使用情况的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" (Assurance Report) regarding the company's 2025 annual fundraising funds deposit, management, and actual usage situation. It is issued by a certified public accounting firm and includes detailed financial data about the fundraising amount, usage, management, and compliance with regulatory rules from the China Securities Regulatory Commission and Shanghai Stock Exchange. The document contains extensive financial tables and explanations about the use of raised funds, cash management, project progress, and compliance with fundraising regulations. It is a standalone audit/assurance report focused on the company's fundraising funds management and usage for the year 2025, not a full annual report or interim report. It is not a mere announcement or certification letter but contains substantive financial and management information related to fundraising funds. Therefore, it fits the category of an Audit Report / Information (AR) rather than Annual Report (10-K) or Regulatory Filings (RNS).
2026-04-29 Chinese
2025年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' (Audit Report) and is issued by a certified public accounting firm (上会会计师事务所). It contains detailed audit opinions, basis for audit opinions, key audit matters, management responsibilities, and auditor responsibilities. It includes comprehensive financial statements such as consolidated balance sheet, income statement, cash flow statement, and changes in shareholders' equity for the fiscal year ending December 31, 2025. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content and structure clearly correspond to a standalone audit report rather than a full annual report or other filing types. Therefore, the document fits the category of Audit Report / Information (AR).
2026-04-29 Chinese
独立董事提名人声明与承诺（王有平）
Board/Management Information Classification · 95% confidence The document is a formal statement from the board nominating an independent director candidate, detailing qualifications, compliance with regulatory requirements, and declarations of independence. It does not contain financial data, earnings, or report content. It is not an announcement of voting results or a proxy solicitation but a nomination statement related to board management. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management nomination, not a full report or announcement of a report.
2026-04-29 Chinese
2025年度环境、社会和公司治理报告
Environmental & Social Information Classification · 100% confidence The document is titled "2025年环境、社会和公司治理报告" which translates to "2025 Environmental, Social and Corporate Governance Report". It is a comprehensive report detailing the company's ESG (Environmental, Social, and Governance) performance, including sections on governance, social responsibility, environmental management, innovation, and sustainability practices. The document includes detailed data on economic, environmental, and social indicators, governance structure, stakeholder communication, and sustainability initiatives. It references international ESG standards and regulatory guidelines. The length is substantial (15,000 characters), and it contains substantive content rather than just an announcement or summary. This matches the description of an Environmental & Social Information report (ESG report). Therefore, the appropriate classification is Environmental & Social Information (Code: SR).
2026-04-29 Chinese
股东会议事规则（2026年4月）
Governance Information Classification · 95% confidence The document is titled as "股东会议事规则" which translates to "Shareholders Meeting Rules" or "Rules of Procedure for Shareholders' Meetings". It extensively details the procedures, rights, responsibilities, and regulations governing the conduct of shareholders' meetings, including the convening, notification, proposal submission, voting, and record-keeping processes. There is no financial data, earnings information, or report content. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial and contains detailed governance rules, not just an announcement or summary. Therefore, the appropriate classification is CGR with high confidence.
2026-04-29 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.